Frankfurt - Delayed Quote EUR

Vertex Pharmaceuticals Incorporated (VX1.F)

Compare
463.00
+38.45
+(9.06%)
As of 10:28:35 AM GMT+1. Market open.
All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating cash flow
-842,600.00
3,537,300.00
4,129,900.00
2,643,500.00
3,253,500.00
Investing cash flow
-3,834,600.00
-3,141,700.00
-321,100.00
-340,900.00
99,400.00
Financing cash flow
-1,223,400.00
-562,200.00
-67,700.00
-1,478,000.00
-505,300.00
End cash position
5,216,000.00
10,372,300.00
10,512,000.00
6,800,100.00
5,988,900.00
Income tax paid supplemental data
1,568,500.00
1,677,300.00
1,057,800.00
476,300.00
191,800.00
Interest paid supplemental data
38,300.00
43,100.00
52,300.00
56,300.00
54,500.00
Capital expenditure
-508,900.00
-258,400.00
-204,700.00
-235,000.00
-259,800.00
Issuance of debt
--
1,800.00
3,500.00
28,300.00
13,300.00
Repayment of debt
-44,300.00
-44,900.00
-85,500.00
-47,000.00
-42,300.00
Repurchase of capital stock
-1,309,600.00
-653,700.00
-172,000.00
-1,561,300.00
-739,400.00
Free cash flow
-1,351,500.00
3,278,900.00
3,925,200.00
2,408,500.00
2,993,700.00
12/31/2020 - 2/2/2000

Upgrade to start utilising 40 years of financial statements and gain so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets and cash flows - all exportable.

Upgrade

Related tickers